image
Healthcare - Biotechnology - NASDAQ - US
$ 39.23
-7.43 %
$ 3.03 B
Market Cap
-6.6
P/E
INCOME STATEMENT
938 M REVENUE
34.20%
-349 M OPERATING INCOME
20.58%
-627 M NET INCOME
-12.09%
EFFICIENCY
Earnings Waterfall PTC Therapeutics, Inc.
image
Revenue 938 M
Cost Of Revenue 65.5 M
Gross Profit 872 M
Operating Expenses 1.31 B
Operating Income -349 M
Other Expenses 277 M
Net Income -627 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
REVENUE
Revenue 937.8 698.8 538.6 380.8 307.0 264.7 194.4 82.7 36.8 23.0 31.3 28.8 99.0
GROSS PROFIT
Cost Of Revenue 65.5 44.7 32.3 18.9 12.1 12.7 4.6 117.6 121.8 79.8 54.9 (5.2) 0
Gross Profit 872.3 654.1 506.3 361.8 294.8 252.1 189.8 (34.9) (85.0) (56.9) (23.5) 33.9 99.0
OPERATING INCOME
Operating Expenses 1 311.8 1 094.0 881.2 759.7 487.6 348.4 254.1 214.8 203.9 122.4 76.7 55.6 68.4
Selling, General and Administrative Expenses 332.5 326.0 285.8 245.2 202.5 153.5 121.3 97.1 82.1 44.8 25.2 14.6 16.2
Research and Development Expenses 666.6 651.5 540.7 477.6 257.5 172.0 117.5 117.6 121.8 79.8 54.9 46.1 58.7
Operating Income (349.4) (439.9) (374.9) (397.9) (192.8) (115.7) (64.3) (132.1) (167.1) (99.4) (45.4) (26.8) 30.6
PRE-TAX INCOME
Interest Income Expense 129.2 90.9 86.0 56.4 12.5 12.6 12.1 8.3 2.4 1.2 0 0 2.4
Total Other Income (346.7) (147.6) (143.4) (59.4) (47.1) (12.4) (13.4) (9.5) (2.8) 1.0 (6.2) 0.6 (2.0)
Pre-Tax Income (696.1) (587.5) (518.3) (402.9) (239.9) (128.1) (77.7) (141.5) (170.0) (98.4) (51.6) (26.2) 28.6
NET INCOME
Tax Provision (69.5) (28.5) 5.6 35.2 11.7 29 K 1.3 0.6 0.5 (4.7) 6.2 1.2 (2.3)
Net Income (626.6) (559.0) (523.9) (438.2) (251.6) (128.1) (79.0) (142.1) (170.4) (93.8) (51.6) (26.2) 30.9
EPS 8.37 7.79 7.43 6.64 4.27 2.75 2.02 4.17 5.07 2.97 4.02 1.85 0.0018